Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Sponsor: Genmab
Summary
This Phase 2 study will be conducted in different countries around the world with up to about 240 participants. The purpose of this study is to evaluate how well Rina-S works against lung cancer. The treatment in this study is Rina-S monotherapy (by itself). All participants will receive active drug; no one will be given placebo. The treatment duration will be different for every participant, but an average of 12 months is expected. Participants will be asked to attend 1 to 5 visits at the study clinic for each cycle (duration of cycle is 3 weeks). If a participant's cancer stays the same or gets better, and there are not any serious problems, participants can keep getting study treatment for as long as the study is open. Participation in the study will require visits to the study site(s). During site visits, there will be various tests (such as blood draws) and procedures (such as recording of heart activity, imaging/X-rays) to monitor whether the study treatment is safe and effective.
Official title: A Phase 2, Open-label, Multicohort Study of Rinatabart Sesutecan (Rina-S) in Participants With Non-Small Cell Lung Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
240
Start Date
2026-01-30
Completion Date
2028-11-22
Last Updated
2026-08-26
Healthy Volunteers
No
Conditions
Interventions
Rina-S
Intravenous (IV) infusion.
Locations (74)
Compassionate Cancer Care Center
Fountain Valley, California, United States
Kaiser Permanente San Diego Mission Road
San Diego, California, United States
Providence Medical Foundation (St. Joseph Heritage Healthcare)
Santa Rosa, California, United States
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, United States
Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Emory Winship Cancer Institute
Atlanta, Georgia, United States
St. Vincent Frontier Cancer Center
Billings, Montana, United States
Nebraska Hematology-Oncology
Lincoln, Nebraska, United States
Astera Cancer Care
East Brunswick, New Jersey, United States
ONE Onc: New York Oncology Hematology
Albany, New York, United States
Montefiore Medical Park
The Bronx, New York, United States
UNC Health - University of North Carolina
Chapel Hill, North Carolina, United States
Williamette Valley Cancer Institute and Research Center
Eugene, Oregon, United States
Providence Portland Medical Center
Portland, Oregon, United States
Providence Oncology & Hematology Care Clinic - Westside
West Haven-Sylvan, Oregon, United States
Tennessee Oncology - Nashville St. Thomas Midtown Clinic
Nashville, Tennessee, United States
Tennessee Oncology Nashville - SCRI Oncology Partners
Nashville, Tennessee, United States
Baylor Charles A. Sammons Cancer Center
Dallas, Texas, United States
Virginia Cancer Specialists
Fairfax, Virginia, United States
St Andrews Medical Centre
Adelaide, Australia
Chris O'Brien Lifehouse
Camperdown, Australia
Icon Cancer Centre Hobart
Hobart, Australia
Icon Cancer Care - Townsville
Hyde Park, Australia
St John of God Murdoch Hospital
Murdoch, Australia
GenesisCare North Shore
Saint Leonards, Australia
Chu Helora Hospital La Louvière Site Jolimont
La Louvière, Belgium
UZ Leuven - Gasthuisberg Campus
Leuven, Belgium
AZ Delta (Campus Wilgenstraat)
Roeselare, Belgium
Shanghai East Hospital
Shanghai, Pudong, China
Beijing Chest Tumor Hospital
Beijing, China
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
The First Affiliated Hospital of Hebei North University
Zhangjiakou, China
Henan Cancer Hospital
Zhengzhou, China
Assistance Publique Hôpitaux de Marseille - Hôpital Nord
Marseille, France
Cochin Hospital
Paris, France
Groupe Hospitalier Paris Saint-Joseph
Paris, France
Institut Curie - Centre de Recherche
Paris, France
Lyon Sud Hospital Center
Pierre-Bénite, France
Evangelische Lungenklinik Berlin
Berlin, Germany
Universitaetsklinikum Essen
Essen, Germany
Krankenhaus Martha-Maria Halle-Dölau
Halle, Germany
Bács-Kiskun Megyei Kórház - Kecskemét
Kecskemét, Hungary
Szent Borbála Hospital
Tatabánya, Hungary
Istituto di Candiolo - IRCCS
Candiolo, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)
Meldola, Italy
Kitasato University Hospital
Sagamihara, Kanagawa, Japan
Kanagawa Cardiovascular and Respiratory Center
Yokohama, Kanagawa, Japan
Kyoto Prefectural University of Medicine
Kyoto, Kyoto, Japan
Japan Community Health Care Organization Chukyo Hospital
Nagoya, Minami Ward, Japan
Saitama Medical University International Medical Center
Saitama, Moroyama, Japan
NHO Kinki Chuo Chest Medical Center
Sakai, Osaka, Japan
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital
Tokyo, Japan
The Netherlands Cancer Institute (NKI)
Amsterdam, Netherlands
Leids Universitair Medisch Centrum
Leiden, Netherlands
Gdański Uniwersytet Medyczny
Gdansk, Poland
KOMED Roman Karaszewski I Wspolnicy Spolka Jawna
Krakow, Poland
Instytut MSF
Lodz, Poland
MedPolonia
Poznan, Poland
Hospital Germans Trias i Pujol
Barcelona, Spain
Parc de Salut Mar - Hospital del Mar
Barcelona, Spain
USP Instituto Universitario Dexeus
Barcelona, Spain
START Rioja
Logroño, Spain
Clinica Universidad de Navarra - Madrid
Madrid, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
MD Anderson Cancer Center Madrid
Madrid, Spain
Hospital Quirón Málaga
Málaga, Spain
Clinica Universidad de Navarra - Pamplona
Pamplona, Spain
Fundación IVO. Instituto Valenciano de Oncología
Valencia, Spain
Hospital Clinico Universitario de Valencia
Valencia, Spain
Changhua Christian Hospital
Changhua, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare
New Taipei City, Taiwan
Chi Mei Medical Center - Liouying
Tainan, Taiwan
National Cheng Kung University
Tainan, Taiwan